Evan Loh, CEO at Paratek Pharmaceuticals, Inc. (PRTK), sold 14,514 shares at $3.10 ($45K) on 2019-12-12, disclosed to the SEC on 2019-12-16.
Open-market sale of $45k PRTK by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PRTK | SELL | 2022-12-14 | $393K | — | Filing → |
| PRTK | SELL | 2022-11-01 | $31K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $237K | — | Filing → |